NJ Bio, Inc. was awarded the 9th Annual World ADC Award for Best Contract Research Provider category at the 13th Annual World ADC Conference 2022 held in San Diego.
Through the years, the Annual World ADC Awards recognizes innovation, and leadership within the antibody-drug conjugates space and the awards are given to recognize long-term commitment to the field with the goal to bring more life changing drugs to patients. “NJ Bio is grateful and humbled to receive the prestigious, Best Contract Research Provider Award, at the 13th Annual World ADC Conference. NJ Bio’s two consecutive wins (the 8th and 9th World ADC Awards, Best Contract Research Provider) in 2021 and 2022 is a testimony to NJ Bio’s commitment to consistently provide high quality CRO services to our ADC clients. We extend our heartfelt gratitude to all our clients for their tremendous and continual support, the Awards Committee, and Hanson Wade for providing us this opportunity. This award is a recognition of the excellent teamwork of our scientists at Princeton site, USA and our affiliate scientists at Amar Chemistry, India, the fact that we stay abreast of all the latest developments in the ADC space and provide value to our clients consistently”, commented Dr Naresh Jain, President, and CEO of NJ Bio.